Cadrenal Therapeutics, Inc. (CVKD)

Cadrenal Therapeutics Market Cap

Cadrenal Therapeutics has a market cap or net worth of $7.54 million as of May 31, 2024. Its market cap has decreased by -55.62% in one year.

• Market Cap: 7.54M
• Enterprise Value: 993.54K
• 1-Year Change: -55.62%
• Ranking: #5325
• Category: Nano-Cap
• Stock Price: $0.47

Market Cap Chart

Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $7.54M, a decrease of -87.03%. That is a compound annual growth rate of -77.69%.

Market Cap History

Date	Market Cap	% Change
May 31, 2024	7.50M	13.64%
May 30, 2024	6.60M	-
May 29, 2024	6.60M	3.13%
May 28, 2024	6.40M	-3.03%
May 24, 2024	6.60M	-1.49%
May 23, 2024	6.70M	1.52%
May 22, 2024	6.60M	-1.49%
May 21, 2024	6.70M	-2.90%
May 20, 2024	6.90M	4.55%
May 17, 2024	6.60M	-4.35%
May 16, 2024	6.90M	-2.82%
May 15, 2024	7.10M	-
May 14, 2024	7.10M	1.43%
May 13, 2024	7.00M	-5.41%
May 10, 2024	7.40M	-5.13%
May 9, 2024	7.80M	-1.27%
May 8, 2024	7.90M	2.60%
May 7, 2024	7.70M	-3.75%
May 6, 2024	8.00M	2.56%
May 3, 2024	7.80M	5.41%
May 2, 2024	7.40M	1.37%
May 1, 2024	7.30M	4.29%
Apr 30, 2024	7.00M	-2.78%
Apr 29, 2024	7.20M	4.35%
Apr 26, 2024	6.90M	1.47%

View and export this data all the way back to 2023. Sign Up Today.

Related Stocks

Company	Market Cap
Pulmatrix	6.94M
Tenax Therapeutics	6.88M
Longeveron	6.86M
Kazia Therapeutics	6.71M
XWELL	6.69M
TFF Pharmaceuticals	6.52M
Protagenic Therapeutics	6.25M
BIOLASE	6.24M